Financial results - NEURODERMAMED SRL

Financial Summary - Neurodermamed Srl
Unique identification code: 35877484
Registration number: J04/456/2016
Nace: 8622
Sales - Ron
14.247
Net Profit - Ron
11.916
Employee
The most important financial indicators for the company Neurodermamed Srl - Unique Identification Number 35877484: sales in 2023 was 14.247 euro, registering a net profit of 11.916 euro and having an average number of employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Neurodermamed Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - 737 2.078 2.580 5.233 7.727 7.961 8.758 14.247
Total Income - EUR - - 737 2.078 2.580 5.233 7.727 7.961 8.758 35.037
Total Expenses - EUR - - 667 1.348 620 193 194 398 314 21.526
Gross Profit/Loss - EUR - - 70 730 1.961 5.040 7.533 7.563 8.444 13.512
Net Profit/Loss - EUR - - 48 668 1.883 4.883 7.350 7.369 8.236 11.916
Employees - - 0 0 0 0 0 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 63.2%, from 8.758 euro in the year 2022, to 14.247 euro in 2023. The Net Profit increased by 3.704 euro, from 8.236 euro in 2022, to 11.916 in the last year.

Check the financial reports for the company - Neurodermamed Srl

Rating financiar

Financial Rating -
Neurodermamed Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Neurodermamed Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Neurodermamed Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Neurodermamed Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Neurodermamed Srl - CUI 35877484

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - 69 0 0 0 0 0 0 0
Current Assets - - 699 2.520 4.822 9.660 16.913 24.093 12.225 39.848
Inventories - - 0 0 0 0 0 0 0 20.790
Receivables - - 0 0 0 0 0 0 6.550 320
Cash - - 699 2.520 4.822 9.660 16.913 24.093 5.674 18.737
Shareholders Funds - - 92 759 2.628 7.461 14.669 21.713 8.285 14.578
Social Capital - - 45 44 43 42 41 40 41 40
Debts - - 676 1.761 2.194 2.199 2.244 2.379 3.940 25.270
Income in Advance - - 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 39.848 euro in 2023 which includes Inventories of 20.790 euro, Receivables of 320 euro and cash availability of 18.737 euro.
The company's Equity was valued at 14.578 euro, while total Liabilities amounted to 25.270 euro. Equity increased by 6.319 euro, from 8.285 euro in 2022, to 14.578 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Neurodermamed Srl

Comments - Neurodermamed Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.